Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2

CAT:
804-HY-W127716-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 - image 1

Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2

  • CAS Number:

    136724-73-7
  • UNSPSC Description:

    Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 is a potent ruthenium-based dye. Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 can bu used as an effective quencher of quantum dots (QDs) fluorescence and the capture probe of virus antigen EV71. Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 can be used sensitive electrogenerated chemiluminescence (ECL) labels for detection of matrix metalloproteinases (MMPs)[1][2][3].
  • Target Antigen:

    Fluorescent Dye
  • Type:

    Dye Reagents
  • Related Pathways:

    Others
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/ru-bpy-2-mcbpy-o-su-ester-pf6-2.html
  • Purity:

    97.0
  • Solubility:

    H2O : 1 mg/mL (ultrasonic;warming)|10 mM in DMSO
  • Smiles:

    O=C(C1=CC=[N](C2=C1)[Ru+2]34([N]5=CC=CC=C5C6=CC=CC=[N]36)([N]7=CC=CC=C7C8=CC=CC=[N]48)[N](C2=C9)=CC=C9C)ON(C%10=O)C(CC%10)=O.[F-][P+5]([F-])([F-])([F-])([F-])[F-].[F-][P+5]([F-])([F-])([F-])([F-])[F-]
  • Molecular Weight:

    1014.66
  • References & Citations:

    [1]Chen L, et al. Dual-color fluorescence and homogeneous immunoassay for the determination of human enterovirus 71. Anal Chem. 2011 Oct 1;83(19):7316-22.|[2]Hirvonen LM, et al. Hydrodynamic Radii of Ranibizumab, Aflibercept and Bevacizumab Measured by Time-Resolved Phosphorescence Anisotropy. Pharm Res. 2016 Aug;33(8):2025-32.|[3]HongfangGao, et al. Highly selective electrogenerated chemiluminescence biosensor for simultaneous detection of matrix metalloproteinase-2 and matrix metalloproteinase-7 in cell secretions. Sensors and Actuators B: Chemical, December 2017, 69-76.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C (Powder, sealed storage, away from moisture and light)
  • Clinical Information:

    No Development Reported